Daniel M. Hancock - 07 Jun 2021 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Director
Signature
/s/ Daniel M. Hancock
Issuer symbol
CYRX
Transactions as of
07 Jun 2021
Net transactions value
-$1,017,918
Form type
4
Filing time
09 Jun 2021, 17:48:37 UTC
Previous filing
07 May 2021
Next filing
23 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $97,300 +10,000 +216% $9.73 14,627 07 Jun 2021 Direct F1
transaction CYRX Common Stock Sale $600,198 -10,000 -68% $60.02 4,627 07 Jun 2021 Direct F1, F2
transaction CYRX Common Stock Options Exercise $97,300 +10,000 +216% $9.73 14,627 08 Jun 2021 Direct F1
transaction CYRX Common Stock Sale $612,320 -10,000 -68% $61.23 4,627 08 Jun 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Option to purchase common stock Options Exercise $0 -10,000 -20% $0.000000 40,000 07 Jun 2021 Common Stock 10,000 $9.73 Direct F1, F3
transaction CYRX Option to purchase common stock Options Exercise $0 -10,000 -25% $0.000000 30,000 08 Jun 2021 Common Stock 10,000 $9.73 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.90 to $60.31, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 1/36 of the options originally granted vested on the 4th day of each month for the twelve months beginning on February 4, 2019.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.84, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.